SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

ANADIS LIMITED (ANX)

Former Name ASX

SHARE PRICES

(updated at weekends)

Former (or subsequent) names

 FROMTO
IMMURON LIMITED05/12/2008
ANADIS LIMITED05/12/2008

Shareholder links

 

REGISTRY:

Computershare, Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

Address: Level 1, 39 Leveson Street, North Melbourne VIC 3051
Tel:  61 3 9018 4880 Fax: 61 3 9018 4881

Date first listed: 30/04/1999
Company Secretary: Mr Graeme Stevens
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Research, development and commercialisation of nutraceutical, pharmaceutical and related therapeutic technology products

name changed to Immuron Limited

05/12/2008

suspension of trading in the securities of Anadis Limited (the "Company") will be lifted immediately, following the release of announcements by the Company providing an update on the Company's activities

11/03/2008

Anadis Ltd announced in August 2007 that revenue from contract manufacture for third parties was anticipated to come in above $8 million for the financial year 2008 - this expected increase in revenue, over 80% on the previous year, was due to the company having secured the manufacturing of a new product line for a new client - without warning or explanation that third party business has been placed into Administration, with outstanding trade debt to Anadis of approximately $400,000 - the company is pursuing the debt left by the defaulting client but the extent and timing of the recovery is uncertain - this trading cash flow shortfall has placed a strain on the immediate financial position of the Company, which requires an injection of external capital - the Company has a number of capital raising initiatives under way the outcome of which should be determined within approximately one week - directors believe it is appropriate that the Company's shares remain suspended from trading until the capital raising has been finalised

12/02/2008

securities of Anadis Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company

06/02/2008

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

     

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Roman ZwolenskiChairman
    Conor GrahamManaging Director, CEO
    Zeil RosenbergCEO, Executive Director
    Graeme StevensCFO22/11/2007
    Roy Robins-BrowneNon Exec Director02/02/1998
    Peter JenkinsNon Exec Director
    Simon SallkaNon Exec Director
    Colin ChapmanNon Exec Director
    Arie NudelDirector

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION

    Date of first appointment, title may have changed.